Why did GAAP EPS fall to $5.80 in the fourth quarter when net income rose 13%?

GAAP EPS was reduced by $2.27 per share because dividend equivalent payments accrued in the quarter related to the $75.00 special dividend. Under the two-class method, these payments reduce earnings applicable to common stockholders. Adjusted EPS of $9.83 excludes many non-cash and one-time items and is the company's preferred measure of underlying performance.

How was the $75 special dividend funded, and what does it mean for leverage?

The dividend was funded by $3.0 billion of new senior secured debt issued on September 19, 2024 (a $1.5 billion 6.00% notes due 2033 and $1.5 billion Tranche L term loans at SOFR + 2.50%) plus existing cash. Long-term debt rose to about $24.3 billion from $19.3 billion, and the stockholders' deficit deepened to $(6.29) billion. Leverage and interest expense are therefore higher going into FY2025, which the guidance reflects.

What is the FY2025 outlook and what drives it?

Management guided to FY2025 net sales of $8.75–$8.95 billion (about 11.5% growth at midpoint) and EBITDA As Defined of $4.615–$4.755 billion, implying a margin of about 52.9%. Growth assumptions are mid-single-digit for commercial OEM, high-single to low-double-digit for commercial aftermarket, and high-single-digit for defense. Management noted the OEM outlook carries risk around build rates.

What is EBITDA As Defined, and why should investors be cautious about it?

EBITDA As Defined is EBITDA adjusted for items such as non-cash stock and deferred compensation, acquisition-related costs, refinancing costs and foreign currency effects. It is used by management and by the company's credit facility covenant. It excludes interest, taxes, depreciation and amortization, and cash integration costs, so it does not reflect debt service, capital replacement needs or taxes. It should be considered alongside GAAP net income and cash flow.

Did operating cash flow keep pace with earnings growth?

Net cash provided by operating activities for FY2024 was $2,045 million, up from $1,375 million in FY2023. This represents a strong increase, though the filing's reconciliation shows that EBITDA As Defined ($4,173 million) is well above operating cash flow, largely due to interest, current taxes and working capital changes, which investors should weigh when assessing cash generation.

TDG 8-K: Earnings & Results

01—Abstract

Summary

Summary of the 8-K filed November 7, 2024. Cited figures are marked; the original filing is the authoritative source.

TransDigm Group reported fiscal Q4 2024 (quarter ended September 30, 2024) and full-year fiscal 2024 results that exceeded its most recent revenue and EBITDA As Defined margin guidance.

Q4 net sales rose 18.0% to $2,185 million^a, with organic growth of 12.2%, while EBITDA As Defined grew 19.3% to $1,149 million at a 52.6% margin (up about 60 basis points). Fiscal 2024 net sales reached $7,940 million (up 20.6%), net income was $1,715 million (up 32.0%), and adjusted EPS was $33.99 (up 32%). Management cited the acquisitions of SEI Industries, the CPI Electron Device Business and Raptor Scientific, which together with a special dividend deployed roughly $6.5 billion of capital over six months.

The most important balance-sheet event is the special dividend of $75.00^b per share, funded by $3.0 billion of new senior secured debt (a $1.5 billion 6.00% notes due 2033 and $1.5 billion Tranche L term loans at SOFR + 2.50%) and cash on hand. Total payments of about $4,348 million, including dividend equivalents, were made on October 18, 2024. Consequently, total TD Group stockholders' deficit widened to $(6,290) million from $(1,984) million, and long-term debt rose to $24,296 million from $19,330 million.

GAAP EPS of $5.80^c in the quarter was reduced by $2.27 for dividend equivalent accruals, so investors should focus on adjusted measures for underlying performance. For fiscal 2025, TransDigm guided to net sales of $8,750–$8,950 million (about 11.5% growth at midpoint), EBITDA As Defined of $4,615–$4,755 million (about 52.9% margin), and adjusted EPS of $35.36–$37.28.

Growth is expected across commercial OEM (mid single digits), commercial aftermarket (high single to low double digits) and defense (high single digits). The guidance implies a meaningful increase in interest expense and a higher share count, and the forward outlook remains subject to OEM build rates, supply chain constraints and indebtedness-related risks.

02—Key points

Key Highlights

Q4 FY2024 net sales of $2,185 million, up 18.0% year over year, with organic growth of 12.2%.
Q4 EBITDA As Defined of $1,149 million (up 19.3%) at a 52.6% margin, about 60 bps higher than the prior-year quarter; excluding recent acquisitions, the margin was about 53.7%.
Full-year FY2024 net sales of $7,940 million (up 20.6%), net income of $1,715 million (up 32.0%), and adjusted EPS of $33.99 (up 32%).
A $75.00 per share special dividend (about $4,348 million including dividend equivalents) was funded by $3.0 billion of new senior secured debt and cash on hand, and paid October 18, 2024.
Total stockholders' deficit widened to $(6,290) million and long-term debt increased to $24,296 million, reflecting the recapitalization.
FY2025 guidance: net sales of $8,750–$8,950 million, EBITDA As Defined of $4,615–$4,755 million, and adjusted EPS of $35.36–$37.28.
Recent acquisitions of SEI Industries, the CPI Electron Device Business and Raptor Scientific contributed to growth and the margin profile.

03—Questions

Frequently Asked Questions

Why did GAAP EPS fall to $5.80 in the fourth quarter when net income rose 13%?
GAAP EPS was reduced by $2.27 per share because dividend equivalent payments accrued in the quarter related to the $75.00 special dividend. Under the two-class method, these payments reduce earnings applicable to common stockholders. Adjusted EPS of $9.83 excludes many non-cash and one-time items and is the company's preferred measure of underlying performance.
How was the $75 special dividend funded, and what does it mean for leverage?
The dividend was funded by $3.0 billion of new senior secured debt issued on September 19, 2024 (a $1.5 billion 6.00% notes due 2033 and $1.5 billion Tranche L term loans at SOFR + 2.50%) plus existing cash. Long-term debt rose to about $24.3 billion from $19.3 billion, and the stockholders' deficit deepened to $(6.29) billion. Leverage and interest expense are therefore higher going into FY2025, which the guidance reflects.
What is the FY2025 outlook and what drives it?
Management guided to FY2025 net sales of $8.75–$8.95 billion (about 11.5% growth at midpoint) and EBITDA As Defined of $4.615–$4.755 billion, implying a margin of about 52.9%. Growth assumptions are mid-single-digit for commercial OEM, high-single to low-double-digit for commercial aftermarket, and high-single-digit for defense. Management noted the OEM outlook carries risk around build rates.
What is EBITDA As Defined, and why should investors be cautious about it?
EBITDA As Defined is EBITDA adjusted for items such as non-cash stock and deferred compensation, acquisition-related costs, refinancing costs and foreign currency effects. It is used by management and by the company's credit facility covenant. It excludes interest, taxes, depreciation and amortization, and cash integration costs, so it does not reflect debt service, capital replacement needs or taxes. It should be considered alongside GAAP net income and cash flow.
Did operating cash flow keep pace with earnings growth?
Net cash provided by operating activities for FY2024 was $2,045 million, up from $1,375 million in FY2023. This represents a strong increase, though the filing's reconciliation shows that EBITDA As Defined ($4,173 million) is well above operating cash flow, largely due to interest, current taxes and working capital changes, which investors should weigh when assessing cash generation.

04—Continue

← View all 8-K filings